Morgan Stanley names Collins to global healthcare banking co-head role: memo
Reuters
Published Dec 07, 2015 03:05PM ET
Morgan Stanley names Collins to global healthcare banking co-head role: memo
(This December 2 story was corrected to change Morgan Stanley's North American ranking from No. 2 to No. 3)
By Mike Stone and Olivia Oran
(Reuters) - Morgan Stanley (N:MS) named John Collins as the co-head of its global healthcare banking group, according to an internal memo on Wednesday. He replaces Clint Gartin, who will become chairman of investment banking.
A veteran mergers and acquisitions banker, Collins most recently served as global operations officer in the investment banking division.
Collins started his career at Morgan Stanley in 1990 as an analyst and was promoted to managing director in 2004. He left to join Moelis & Co (N:MC) in 2010 before rejoining Morgan Stanley in 2013.
Collins will work alongside healthcare banking co-head Michele Colocci and will focus on building out the firm's global client base. He will start at his new role in January.
Gartin joined Morgan Stanley in 1981 and became a managing director in 1991. He has held a number of roles within the firm, including chief administrative officer of investment banking and most recently, vice chairman of investment banking and global co-head of healthcare.
A Morgan Stanley spokeswoman confirmed the contents of the memo.
Morgan Stanley ranks No. 2, both in the United States and globally, in the M&A advisory league tables. The healthcare group has advised on high profile deals recently including Pfizer Inc's (N:PFE) $160 billion deal for Allergan PLC (N:AGN) and Shire PLC's (L:SHP) and Perrigo Company PLC's (N:PRGO) successful defense against a $31 billion hostile takeover attempt by Mylan NV (O:MYL).
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.